Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats

Binnie, 1989, Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy, Epilepsy Res., 4, 222, 10.1016/0920-1211(89)90007-7 Birnstiel, 1991, Anticonvulsants do not suppress long-term potentiation (LTP) in the rat hippocampus, Neurosci. Lett., 14, 61, 10.1016/0304-3940(91)90193-W Bliss, 1993, A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0 Callaghan, 1980, Pharmacological modification of amygdaloid-kindled seizures, Neuropharmacology, 19, 1131, 10.1016/0028-3908(80)90113-6 Cohen, 1987, Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans, Clin. Pharmacol. Ther., 42, 535, 10.1038/clpt.1987.193 Coulter, 1989, Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons, Ann. Neurol., 25, 582, 10.1002/ana.410250610 During, 1993, Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain (see comments), Lancet, 341, 1607, 10.1016/0140-6736(93)90754-5 Ehle, 1980, Effects of phenytoin on amygdaloid kindled seizures in the rat, Electroencephalogr. Clin. Neurophysiol., 48, 102, 10.1016/0013-4694(80)90049-8 Geula, 1988, Long-term enhancement of K+-evoked release of l-glutamate in entorhinal kindled rats, Brain Res., 442, 368, 10.1016/0006-8993(88)91528-4 Griffith, 1988, Phenytoin reduces excitatory synaptic transmission and post-tetanic potentiation in the in vitro hippocampus, J. Pharmacol. Exp. Ther., 246, 851 Jawad, 1989, Controlled trial of lamotrigine (Lamictal) for refractory partial seizures, Epilepsia, 30, 356, 10.1111/j.1528-1157.1989.tb05309.x Leach, 1986, Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action, Epilepsia, 27, 490, 10.1111/j.1528-1157.1986.tb03573.x Lorge, 1963, Erfahrungen mit einem neuen Antiepilepticum, Tegtetol (G 32 883), mit besonderer Wirkung auf die epileptische WesensverSnderung, Schweiz Med. Wochensch., 93, 1042 Löscher, 1993, Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain, Neurochem. Res., 18, 485, 10.1007/BF00967253 McNamara, 1989, Intravenous phenytoin is an effective anticonvulsant in the kindling model, Ann. Neurol., 26, 675, 10.1002/ana.410260514 Messenheimer, 1995, Lamotrigine, Epilepsia, 36, 87, 10.1111/j.1528-1157.1995.tb06002.x Miller, 1986, Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats, Epilepsia, 27, 483, 10.1111/j.1528-1157.1986.tb03572.x Morimoto, 1991, Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP, Pharmacol. Biochem. Behav., 40, 893, 10.1016/0091-3057(91)90103-9 Morimoto, 1997, Antiepileptic effects of Tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy, Epilepsia, 38, 966, 10.1111/j.1528-1157.1997.tb01478.x Namba, 1994, Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the kindling model of epilepsy, Brain Res., 638, 36, 10.1016/0006-8993(94)90630-0 O'Donnell, 1991, The effect of lamotrigine upon development of cortical kindled seizures in the rat, Neuropharmacology, 30, 253, 10.1016/0028-3908(91)90152-2 Peck, A.W., 1991. Clinical pharmacology of lamotrigine. Epilepsia 32 (Suppl. 2), S9–S12. Racine, 1972, Modification of seizure activity by electrical stimulation. II. Motor seizure, Electroencephalogr. Clin. Neurophysiol., 32, 281, 10.1016/0013-4694(72)90177-0 Richens, 1975, Serum phenytoin levels in the management of epilepsy, Lancet, 2, 247, 10.1016/S0140-6736(75)90962-9 Sato, 1988, Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy, Brain Res., 463, 12, 10.1016/0006-8993(88)90521-5 Schlumberger, 1994, Lamotrigine in treatment of 120 children with epilepsy, Epilepsia, 35, 359, 10.1111/j.1528-1157.1994.tb02445.x Teyler, 1987, Long-term potentiation, Annu. Rev. Neurosci., 10, 131, 10.1146/annurev.ne.10.030187.001023 Thompson, 1981, Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy, Br. J. Clin. Psychol., 20, 155, 10.1111/j.2044-8260.1981.tb00513.x Ueda, 1995, Simultaneous monitoring of the seizure-related changes in extracellular glutamate and gamma-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling, Epilepsy Res., 20, 213, 10.1016/0920-1211(94)00081-7 Wheatley, 1989, Effects of lamotrigine on electrically induced afterdischarge duration in anaesthetised rat, dog, and marmoset, Epilepsia, 30, 34, 10.1111/j.1528-1157.1989.tb05277.x Wilder, B.J., 1995. Phenytoin clinical use. In: Rene, H.L., Richard, H.M., Brain, S.M. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 339–344. Yaari, 1986, Phenytoin: mechanisms of its anticonvulsant action, Ann. Neurol., 20, 171, 10.1002/ana.410200202 Yuen, A.W., 1994. Lamotrigine: a review of antiepileptic efficacy. Epilepsia 35 (Suppl. 5), S33–S36.